{"schema_version":"secwatch.filing_event.v1","accession":"0001121781-21-000023","form_type":"8-K","ticker":"GTHP","cik":"0000924515","company_name":"GUIDED THERAPEUTICS INC","filed_at":"2021-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.302190+00:00","generated_at":"2026-06-30T02:25:53.464924+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Guided Therapeutics shareholders approve reverse split and charter changes at annual meeting","bullets":["All seven proposals approved at July 22, 2021 annual meeting.","Reverse split up to 1-for-20 authorized; board may decide by Dec 31, 2021; 15.58M for.","Authorized common reduced from 3B to 500M shares; 15.69M for.","Series F preferred authorized increased to 4,000 from 1,500; 15.51M for.","Advisory compensation vote and one-year frequency approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001121781-21-000023","json":"https://secwatch.observer/filing/0001121781-21-000023.json","markdown":"https://secwatch.observer/filing/0001121781-21-000023.md","text":"https://secwatch.observer/filing/0001121781-21-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/924515/000112178121000023/0001121781-21-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/924515/000112178121000023/gthp8k72721.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T02:25:53.464924+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}